Cargando…
Inhibition of HCV by the serpin antithrombin III
BACKGROUND: Although there have been dramatic strides made recently in the treatment of chronic hepatitis C virus infection, interferon-α based therapy remains challenging for certain populations, including those with unfavorable IL28B genotypes, psychiatric co-morbidity, HIV co-infection, and decom...
Autores principales: | Asmal, Mohammed, Seaman, Michael, Lin, Wenyu, Chung, Raymond T, Letvin, Norman L, Geiben-Lynn, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519617/ https://www.ncbi.nlm.nih.gov/pubmed/23031791 http://dx.doi.org/10.1186/1743-422X-9-226 |
Ejemplares similares
-
In Vivo Anti-HIV Activity of the Heparin-Activated Serine Protease Inhibitor Antithrombin III Encapsulated in Lymph-Targeting Immunoliposomes
por: Asmal, Mohammed, et al.
Publicado: (2012) -
Serpin Induced Antiviral Activity of Prostaglandin Synthetase-2 against HIV-1 Replication
por: Whitney, James B., et al.
Publicado: (2011) -
Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000) -
SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017) -
Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015)